New research finds a strong link between healthcare-associated infections (HAIs) and patient readmission after an initial hospital stay. The findings, published in the June 2012 issue of Infection Control and Hospital Epidemiology, ...
May 4, 2012
0
0
(HealthDay)—Use of fidaxomicin and bezlotoxumab is suggested in specific cases for management of Clostridioides difficile infection (CDI), according to a clinical practice guideline update issued by the Infectious Diseases ...
Jul 12, 2021
0
2
To combat the rise of drug-resistant bacteria, researchers are examining how one superbug adapts to fight an antibiotic of last resort, hoping to find clues that can prolong the drug's effectiveness.
Aug 12, 2019
0
4
Researchers have developed a novel combination therapy using an anticancer agent, mitoxantrone (MTX), together with an antibiotic, vancomycin, for treating bacteria that are resistant to the vancomycin, which is also known ...
Mar 7, 2023
0
61
The national practice guideline for treating MRSA-related pneumonia is seven to 21 days. A Henry Ford Hospital study found that effective treatment can be done in half the time.
Oct 19, 2012
0
0
Canada should ban off-label use of antibiotics in farm animals because it contributes significantly to antibiotic resistance in humans, states an editorial in CMAJ (Canadian Medical Association Journal).
Jun 4, 2012
0
0
The antibiotic most commonly prescribed to treat bloodstream infections in dialysis patients may not always be the best choice, according to a study appearing in an upcoming issue of the Journal of the American Society of ...
Aug 16, 2012
0
0
A new study published in BioMed Central's open access journal Antimicrobial Resistance and Infection Control reports of a phenomenon that could help control the spread of hospital-acquired infections: a surface-coating of ...
Nov 13, 2012
0
0
(HealthDay)—Use of fecal microbiota transplantation (FMT) is cost-effective for recurrent Clostridium difficile infection (CDI), according to a study published in the December issue of the Journal of Gastroenterology and ...
Dec 12, 2016
0
1
A drug approved just two years ago for treating bacterial infections may hold promise for treating the potentially fatal MRSA pneumonia, according to a Henry Ford Hospital study.
Sep 11, 2013
0
0
